- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lung Fibrosis Interstitial
Total 59030 results
-
GlaxoSmithKlineTerminatedIdiopathic Pulmonary FibrosisUnited Kingdom
-
University of AarhusEurostarsUnknownFeasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF) (3-IPF)Idiopathic Pulmonary FibrosisDenmark
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisCanada, United States, Netherlands, France, Italy, Germany
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; Columbia... and other collaboratorsCompletedIdiopathic Pulmonary FibrosisUnited States
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Israel, Australia, Italy, Canada, United Kingdom, Switzerland, Germany, Poland, Czechia, Belgium, France
-
Genentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisGermany, United Kingdom, Ireland, France, Austria, Denmark, Finland, Italy, Norway, Sweden
-
Genentech, Inc.CompletedIdiopathic Pulmonary Fibrosis | Pulmonary FibrosisUnited States
-
Genentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheInterMune Deutschland GmbHCompletedIdiopathic Pulmonary FibrosisGermany
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Australia, Canada, Czech Republic, Germany, Ireland, Israel, Italy, Switzerland
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Netherlands, Japan, Germany, Czech Republic, Italy, Switzerland, Austria, Croatia, Ireland, Israel, Serbia
-
Genentech, Inc.Approved for marketingIdiopathic Pulmonary Fibrosis
-
Genzyme, a Sanofi CompanyCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium
-
US Department of Veterans AffairsCompletedIdiopathic Pulmonary FibrosisUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research InstituteTerminatedIdiopathic Pulmonary FibrosisUnited States
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, Israel, Spain, Australia, France, Canada, Turkey, Germany, Italy, South Africa, Slovenia, Sweden
-
ImmuneWorksCompletedIdiopathic Pulmonary FibrosisUnited States
-
Institut National de la Santé Et de la Recherche...CompletedIdiopathic Pulmonary Fibrosis
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, United Kingdom, Switzerland, Israel, Canada, France, Germany, Italy
-
Rabin Medical CenterUnknownIdiopathic Pulmonary FibrosisIsrael
-
InterMuneCompletedIdiopathic Pulmonary FibrosisUnited States
-
Dennis Jensen, Ph.D.UnknownChronic Obstructive Pulmonary Disease | Interstitial Lung DiseaseCanada
-
Yonsei UniversityRecruitingIdiopathic Pulmonary Fibrosis With Acute ExacerbationKorea, Republic of
-
National Institute of Geriatrics, Rheumatology...Medical Research Agency, PolandNot yet recruitingSystemic Sclerosis | Interstitial Lung DiseasePoland
-
aTyr Pharma, Inc.Recruiting
-
Medical University of SilesiaRecruitingChronic Obstructive Pulmonary Disease | Interstitial Lung DiseasePoland
-
Central Hospital, Nancy, FranceRecruitingSystemic Sclerosis | Interstitial Lung DiseaseFrance
-
Central Hospital, Nancy, FranceRecruitingSystemic Sclerosis | Interstitial Lung DiseaseFrance
-
University of Milano BicoccaCompletedPneumonia, Viral | Emphysema | COVID | Interstitial Lung Disease | Bronchiectasis Adult | BarotraumaItaly
-
Genentech, Inc.CompletedSystemic SclerosisUnited States, Canada, Italy
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenRecruitingNSCLC | Lung Diseases, Interstitial | ImmunotherapyBelgium
-
Bristol-Myers SquibbCompletedHealthy Participants | Idiopathic Pulmonary Fibrosis (IPF)United States
-
Jianwu DaiSouthwest Hospital, ChinaCompletedPost-radiotherapy Pulmonary FibrosisChina
-
Central Hospital, Nancy, FranceRecruitingSystemic Sclerosis | Interstitial Lung DiseaseFrance
-
Medical University InnsbruckBoehringer IngelheimRecruitingConnective Tissue Diseases | Systemic Sclerosis | Interstitial Lung DiseaseAustria
-
Evans Fernandez PerezGenentech, Inc.TerminatedInterstitial Lung DiseaseUnited States
-
University of PennsylvaniaNational Cancer Institute (NCI)TerminatedPortal Hypertension | Liver FibrosesUnited States
-
Guangzhou Institute of Respiratory DiseaseUnknownDiffuse Parenchymal Lung DiseasesChina
-
AmMax Bio, Inc.Withdrawn
-
Novartis PharmaceuticalsTerminatedIdiopathic Pulmonary FibrosisUnited States, United Kingdom
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States, New Zealand, India, South Africa, Australia, Bulgaria, Canada
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); Brown UniversityCompleted
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI)WithdrawnHealthy | Idiopathic Pulmonary FibrosisUnited States
-
University of MichiganCoalition for Pulmonary FibrosisCompletedIdiopathic Pulmonary FibrosisUnited States
-
University of Modena and Reggio EmiliaNot yet recruiting
-
Imperial College LondonUniversity of Nottingham; University College, London; University of Sheffield; Medical... and other collaboratorsRecruitingInterstitial Lung Disease | SARS-CoV-2 InfectionUnited Kingdom
-
Cedars-Sinai Medical CenterGenentech, Inc.Recruiting